Aeon Biopharma Inc.
13F holders, Q1 2024 (March 31)27holders
1famous investor
$10.92avg. 13F price*
At the end of Q1 2024, 27 institutions reported holding Aeon Biopharma Inc. in their 13F filings. The largest holders were Polar Asset Management Partners Inc. ($42.6M), Atalaya Capital Management LP ($36.2M) and Vanguard Group Inc. ($8.8M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.7M |
| Exits | 1 | $5K |
Ownership 27 holders
| Polar Asset Management Partners Inc. | 1.52% | Reduce -5.2% | 3,675,000 | $42.6M |
| Atalaya Capital Management LP | 44.58% | No change | 3,675,000 | $36.2M |
| Vanguard Group Inc. | 0.00% | Add +261.8% | 758,992 | $8.8M |
| Ikarian Capital, LLC | 0.81% | No change | 257,977 | $3.0M |
| BlackRock Inc. | 0.00% | Add +3.4% | 255,423 | $3.0M |
| Geode Capital Management, LLC | 0.00% | Add +4.3% | 179,595 | $2.1M |
| Goldman Sachs Group Inc. | 0.00% | Add +812.3% | 169,158 | $2.0M |
| Formidable Asset Management, LLC | 0.13% | Add +17.2% | 68,193 | $791K |
| Qube Research & Technologies Ltd | 0.00% | Add +1424.3% | 59,815 | $694K |
| State Street Corp. | 0.00% | Add +492.5% | 59,550 | $691K |
| Millennium Management | 0.00% | New | 55,987 | $649K |
| Boothbay Fund Management, LLC | 0.02% | No change | 55,062 | $639K |
| Northern Trust Corp. | 0.00% | Reduce -2.0% | 48,813 | $566K |
| Jane Street Group, LLC | 0.00% | New | 36,250 | $421K |
| JPMorgan Chase & Co. | 0.00% | Add +313.7% | 28,498 | $331K |
| Bank of America Corp. | 0.00% | Reduce -1.5% | 22,995 | $267K |
| Shaolin Capital Management LLC | 0.10% | New | 21,380 | $248K |
| Royal Bank of Canada | 0.00% | New | 14,400 | $167K |
| Morgan Stanley | 0.00% | Add +478.0% | 10,404 | $121K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 10,001 | $116K |
| LMR Partners LLP | 0.00% | New | 6,608 | $77K |
| GHP Investment Advisors, Inc. | 0.00% | No change | 1,095 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +876.8% | 967 | $11K |
| Catalyst Funds Management Pty Ltd | 0.00% | — | 285 | $3K |
| Wells Fargo & Company | 0.00% | Add +1.5% | 139 | $2K |
| Dupont Capital Management Corp. | 0.00% | No change | 3 | $35 |
| Macquarie Group Ltd. | 0.00% | New | 901 | $10 |
"% of holder's portfolio" is AEON BIOPHARMA INC's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.